Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2023 07:00 ET | Source: BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Plc: Notice to the BBS-Bioactive Bone Substitutes Plc’s Annual General Meeting

BBS-Bioactive Bone Substitutes Plc, Company Announcement, 9 March 2023 at 2.00 pm (EET) The shareholders of BBS-Bioactive Bone Substitutes Plc are invited to the company’s Annual General Meeting,...
March 09, 2023 07:00 ET | Source: BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Oyj: BBS-Bioactive Bone Substitutes Oyj: Vuoden 2022 vuosikertomus on julkaistu

BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote, 9.3.2023 klo 14:00 BBS-Bioactive Bone Substitutes Oyj:n vuoden 2022 vuosikertomus on julkaistu tänään osoitteessa...
March 09, 2023 07:00 ET | Source: BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Plc: BBS-Bioactive Bone Substitutes Plc: Annual Report for 2022 has been published

BBS-Bioactive Bone Substitutes Plc, Company announcement, 9 March 2023, 2:00 PM BBS-Bioactive Bone Substitutes Plc Annual Report for 2022 has been published 9 March 2023. The publication is...
March 09, 2023 07:00 ET | Source: BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Oyj: Kutsu BBS-Bioactive Bone Substitutes Oyj:n varsinaiseen yhtiökokoukseen

BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote 9.3.2023, klo 14.00 BBS-Bioactive Bone Substitutes Oyj:n osakkeenomistajat kutsutaan yhtiön varsinaiseen yhtiökokoukseen, joka pidetään yhtiön...
February 24, 2023 08:00 ET | Source: BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 1.1.-31.12.2022 (tilintarkastamaton)

BBS-Bioactive Bone Substitutes Oyj, tilinpäätöstiedote, 24.2.2023 klo 15.00 BBS:n ensimmäisen tuotteen CE-merkintäprosessi etenee Tämä tiedote on tiivistelmä BBS-Bioactive Bone Substitutes...
February 24, 2023 08:00 ET | Source: BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Plc: Financial Statements Bulletin, 1 January – 31 December 2022 (unaudited)

BBS-Bioactive Bone Substitutes Plc, Financial Statements Bulletin, 24 February 2023 at 3.00 p.m. BBS advances towards the CE marking of its first product This is a summary of BBS-Bioactive...
February 16, 2023 12:45 ET | Source: BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes: Nasdaq First North Growth Market Swedenin rinnakkaislistauksen poisto hyväksytty

BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote, 16.2.2023 klo 19.45 BBS-Bioactive Bone Substitutes: Nasdaq First North Growth Market Swedenin rinnakkaislistauksen poisto hyväksytty ...
February 16, 2023 12:45 ET | Source: BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes: Approved delisting application regarding the secondary listing on the Nasdaq First North Growth Market Sweden

BBS-Bioactive Bone Substitutes Oyj, Company release, 16 February 2023 at 7.45 pm EET BBS-Bioactive Bone Substitutes: Approved delisting application regarding the secondary listing on the Nasdaq...
February 13, 2023 04:00 ET | Source: BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes on hakenut Nasdaq First North Growth Market Swedenin rinnakkaislistauksesta luopumista

BBS-Bioactive Bone Substitutes, yhtiötiedote, 13.2.2023 klo 11.00 BBS-Bioactive Bone Substitutes on hakenut Nasdaq First North Growth Market Swedenin rinnakkaislistauksesta luopumista ...
February 13, 2023 04:00 ET | Source: BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Plc Applies for The Delisting of Secondary Listing on Nasdaq First North Growth Market Sweden

BBS-Bioactive Bone Substitutes Oyj, Company release, 13 February 2023 at 11.00 am EET BBS-Bioactive Bone Substitutes Applies for The Delisting of Secondary Listing on Nasdaq First North Growth...